Recently, it was shown that inhibitors of activated CaMKII significantly decrease neuronal damage even if applied one hour after an experimental stroke in vivo or 2–6 hours after an excitotoxic insult in neuronal cultures [2,3,4]. This evidence concerns the gene CAMK2G and stroke disorder.